Dianthus Therapeutics, Inc. /DE/ Comprehensive Income
Dianthus Therapeutics, Inc. /DE/ (DNTH) reported Comprehensive Income of -$51.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$51.77M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$41.90M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$64.11M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$36.70M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$161.95M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$84.91M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$43.35M.
- Dianthus Therapeutics, Inc. /DE/ comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$28.64M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$51.77M 10-Q · filed 2026-08-04 | -$93.67M 10-Q · filed 2026-08-04 | -$157.77M derived: sum of 3 quarters · filed 2026-08-04 | -$194.47M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | -$41.90M 10-Q · filed 2026-05-05 | -$106.00M derived: sum of 2 quarters · filed 2026-05-05 | -$142.70M derived: sum of 3 quarters · filed 2026-05-05 | -$174.50M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | -$64.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$100.81M derived: sum of 2 quarters · filed 2026-03-09 | -$132.61M derived: sum of 3 quarters · filed 2026-08-04 | -$161.95M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$36.70M 10-Q · filed 2025-11-05 | -$68.50M derived: sum of 2 quarters · filed 2026-08-04 | -$97.85M 10-Q · filed 2025-11-05 | -$126.86M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | -$31.80M 10-Q · filed 2026-08-04 | -$61.15M 10-Q · filed 2026-08-04 | -$90.16M derived: sum of 3 quarters · filed 2026-08-04 | -$114.62M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | -$29.35M 10-Q · filed 2026-05-05 | -$58.36M derived: sum of 2 quarters · filed 2026-05-05 | -$82.82M derived: sum of 3 quarters · filed 2026-05-05 | -$100.44M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$29.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$53.47M derived: sum of 2 quarters · filed 2026-03-09 | -$71.09M derived: sum of 3 quarters · filed 2026-03-09 | -$84.91M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | -$24.46M 10-Q · filed 2025-11-05 | -$42.07M derived: sum of 2 quarters · filed 2025-11-05 | -$55.90M 10-Q · filed 2025-11-05 | -$66.41M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | -$17.62M 10-Q · filed 2025-08-07 | -$31.44M 10-Q · filed 2025-08-07 | -$41.95M derived: sum of 3 quarters · filed 2025-08-07 | -$56.70M derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | -$13.82M 10-Q · filed 2025-05-12 | -$24.33M derived: sum of 2 quarters · filed 2025-05-12 | -$39.08M derived: sum of 3 quarters · filed 2025-05-12 | -$50.18M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | -$10.51M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$25.26M derived: sum of 2 quarters · filed 2025-03-11 | -$36.36M derived: sum of 3 quarters · filed 2025-03-11 | -$43.35M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$14.75M 10-Q · filed 2024-11-07 | -$25.85M derived: sum of 2 quarters · filed 2024-11-07 | -$32.84M 10-Q · filed 2024-11-07 | -$42.96M derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | -$11.10M 10-Q · filed 2024-08-08 | -$3.27M 10-Q · filed 2023-08-03 | -$18.09M 10-Q · filed 2024-08-08 | -$32.28M 10-Q · filed 2023-08-03 | -$28.21M derived: sum of 3 quarters · filed 2024-08-08 | -$36.15M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | -$6.99M 10-Q · filed 2024-05-09 | -$29.00M 10-Q · filed 2023-05-15 | -$17.11M derived: sum of 2 quarters · filed 2024-05-09 | -$25.05M derived: sum of 3 quarters · filed 2024-05-09 | -$42.45M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$10.13M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$18.06M derived: sum of 2 quarters · filed 2024-03-21 | -$35.47M derived: sum of 3 quarters · filed 2024-03-21 | -$28.64M 10-K · filed 2024-03-21 | -$76.61M 10-K · filed 2023-03-23 | |||
| 2022-09-30 | -$7.93M 10-Q · filed 2023-11-09 | -$15.92M 10-Q · filed 2022-11-03 | -$25.34M derived: sum of 2 quarters · filed 2023-11-09 | -$18.51M 10-Q · filed 2023-11-09 | -$56.72M 10-Q · filed 2022-11-03 | -$10.02M derived: sum of 4 quarters · filed 2023-12-21 | ||
| 2022-06-30 | -$17.40M 10-Q · filed 2023-08-03 | -$40.79M 10-Q · filed 2023-08-03 | -$2.08M derived: sum of 3 quarters · filed 2023-12-21 | -$19.51M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2022-03-31 | -$23.39M 10-Q · filed 2023-05-15 | $15.32M derived: sum of 2 quarters · filed 2023-12-21 | -$2.11M derived: sum of 3 quarters · filed 2023-12-21 | -$19.04M derived: sum of 4 quarters · filed 2023-12-21 | ||||
| 2021-12-31 | $38.71M derived: 8-K 12 month − 10-Q 9 month · filed 2023-12-21 | $21.28M derived: sum of 2 quarters · filed 2023-12-21 | $4.35M derived: sum of 3 quarters · filed 2023-12-21 | -$13.11M 8-K · filed 2023-12-21 | -$71.14M 10-K · filed 2022-03-08 | |||
| 2021-09-30 | -$17.43M 10-Q · filed 2022-11-03 | -$34.36M derived: sum of 2 quarters · filed 2022-11-03 | -$51.82M 10-Q · filed 2022-11-03 | -$70.05M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | -$16.93M 10-Q · filed 2022-08-04 | -$34.39M 10-Q · filed 2022-08-04 | -$52.62M derived: sum of 3 quarters · filed 2022-08-04 | -$70.41M derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | -$17.46M 10-Q · filed 2022-05-16 | -$35.69M derived: sum of 2 quarters · filed 2022-05-16 | -$53.48M derived: sum of 3 quarters · filed 2022-05-16 | -$72.77M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$18.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$36.02M derived: sum of 2 quarters · filed 2022-03-08 | -$55.31M derived: sum of 3 quarters · filed 2022-03-08 | -$74.97M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$17.79M 10-Q · filed 2021-11-04 | -$37.08M derived: sum of 2 quarters · filed 2021-11-04 | -$56.74M 10-Q · filed 2021-11-04 | -$80.05M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$19.29M 10-Q · filed 2021-08-05 | -$38.95M 10-Q · filed 2021-08-05 | -$62.26M derived: sum of 3 quarters · filed 2021-08-05 | -$83.30M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$19.66M 10-Q · filed 2021-05-06 | -$42.97M derived: sum of 2 quarters · filed 2021-05-06 | -$64.01M derived: sum of 3 quarters · filed 2021-05-06 | -$81.62M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$23.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$44.36M derived: sum of 2 quarters · filed 2021-03-03 | -$61.97M derived: sum of 3 quarters · filed 2021-03-03 | -$76.75M 10-K · filed 2021-03-03 | ||||
| 2019-09-30 | -$21.05M 10-Q · filed 2020-11-05 | -$38.66M derived: sum of 2 quarters · filed 2020-11-05 | -$53.44M 10-Q · filed 2020-11-05 | -$70.13M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | -$17.61M 10-Q · filed 2020-08-06 | -$32.40M 10-Q · filed 2020-08-06 | -$49.08M derived: sum of 3 quarters · filed 2020-08-06 | -$65.10M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$14.79M 10-Q · filed 2020-05-07 | -$31.47M derived: sum of 2 quarters · filed 2020-05-07 | -$47.49M derived: sum of 3 quarters · filed 2020-05-07 | -$61.15M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | -$16.69M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$32.70M derived: sum of 2 quarters · filed 2020-03-03 | -$46.36M derived: sum of 3 quarters · filed 2020-03-03 | -$57.52M 10-K · filed 2020-03-03 | ||||
| 2018-09-30 | -$16.02M 10-Q · filed 2019-11-13 | -$29.68M derived: sum of 2 quarters · filed 2019-11-13 | -$40.84M 10-Q · filed 2019-11-13 | -$48.87M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-06-30 | -$13.66M 10-Q · filed 2019-08-08 | -$24.82M 10-Q · filed 2019-08-08 | -$32.86M derived: sum of 3 quarters · filed 2020-03-03 | -$39.77M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2018-03-31 | -$11.16M 10-Q · filed 2019-05-09 | -$19.20M derived: sum of 2 quarters · filed 2020-03-03 | -$26.11M derived: sum of 3 quarters · filed 2020-03-03 | -$41.84M derived: sum of 4 quarters · filed 2020-03-03 | ||||
| 2017-12-31 | -$8.04M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-03 | -$14.95M derived: sum of 2 quarters · filed 2020-03-03 | -$30.68M derived: sum of 3 quarters · filed 2020-03-03 | -$35.49M 10-K · filed 2020-03-03 | ||||
| 2017-09-30 | -$6.91M 10-Q · filed 2018-11-08 | -$22.64M derived: sum of 2 quarters · filed 2018-11-08 | -$27.45M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$15.73M 10-Q · filed 2018-08-09 | -$20.54M 10-Q · filed 2018-08-09 | ||||||
| 2016-12-31 | -$9.43M 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |